ID   PANDA
AC   CVCL_B7A6
SY   PANncreatic Ductal Adenocarcinoma
DR   cancercelllines; CVCL_B7A6
DR   Wikidata; Q112129487
RX   PubMed=34818028;
CC   Doubling time: 36 hours (PubMed=34818028).
CC   Karyotypic information: Complex hypertriploid karyotype (PubMed=34818028).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=34818028).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=34818028).
CC   Omics: Metabolome analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=34818028
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=34818028; DOI=10.4149/neo_2021_210924N1360;
RA   Zahumenska R., Kalman M., Marcinek J., Mersakova S., Kertys M.,
RA   Pindura M., Palkoci B., Kycina R., Vojtko M., Chromec T.,
RA   Dumortier H.M., Skovierova H., Novakova S., Mitruskova B.,
RA   Kapralik I., Loderer D., Grendar M., Brany D., Mokry J., Bouvet M.,
RA   Valasek M.A., Janik J., Plank L., Laca L., Halasova E., Strnadel J.;
RT   "Establishment of PANDA -- a new human pancreatic ductal adenocarcinoma
RT   cell line with 3D cell culture technology.";
RL   Neoplasma 69:165-173(2022).
//